Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2008 1
2010 1
2012 1
2013 1
2014 2
2015 4
2016 5
2017 1
2018 3
2019 1
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
Poloznikov AA, Nersisyan SA, Hushpulian DM, Kazakov EH, Tonevitsky AG, Kazakov SV, Vechorko VI, Nikulin SV, Makarova JA, Gazaryan IG. Poloznikov AA, et al. Among authors: kazakov sv. Front Pharmacol. 2021 Jan 29;11:621054. doi: 10.3389/fphar.2020.621054. eCollection 2020. Front Pharmacol. 2021. PMID: 33584306 Free PMC article. Review.
Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2.
Popov A, Klimovich A, Styshova O, Tsybulsky A, Hushpulian D, Osipyants A, Khristichenko A, Kazakov S, Ahuja M, Kaidery N, Thomas B, Tishkov V, Brown A, Gazaryan I, Poloznikov A. Popov A, et al. Among authors: kazakov s. Molecules. 2022 Jan 19;27(3):628. doi: 10.3390/molecules27030628. Molecules. 2022. PMID: 35163891 Free PMC article.
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.
Poloznikov AA, Nikulin SV, Hushpulian DM, Khristichenko AY, Osipyants AI, Asachenko AF, Shurupova OV, Savin SS, Lee SH, Gaisina IN, Thatcher GRJ, Narciso A, Chang EP, Kazakov SV, Krucher N, Tishkov VI, Thomas B, Gazaryan IG. Poloznikov AA, et al. Among authors: kazakov sv. Antioxidants (Basel). 2022 Jan 24;11(2):220. doi: 10.3390/antiox11020220. Antioxidants (Basel). 2022. PMID: 35204103 Free PMC article.
Draft Genome Sequence of Serratia grimesii Strain A2.
Mardanova AM, Toymentseva AA, Gilyazeva AG, Kazakov SV, Shagimardanova EI, Khaitlina SY, Sharipova MR. Mardanova AM, et al. Among authors: kazakov sv. Genome Announc. 2014 Sep 18;2(5):e00937-14. doi: 10.1128/genomeA.00937-14. Genome Announc. 2014. PMID: 25237029 Free PMC article.
De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy.
Kiselev A, Vaz R, Knyazeva A, Khudiakov A, Tarnovskaya S, Liu J, Sergushichev A, Kazakov S, Frishman D, Smolina N, Pervunina T, Jorholt J, Sjoberg G, Vershinina T, Rudenko D, Arner A, Sejersen T, Lindstrand A, Kostareva A. Kiselev A, et al. Among authors: kazakov s. Hum Mutat. 2018 Sep;39(9):1161-1172. doi: 10.1002/humu.23559. Epub 2018 Jun 17. Hum Mutat. 2018. PMID: 29858533
28 results